ACOG Committee Opinion: number 281, December 2002. Rubella vaccination.
The incidence of rubella decreased from 0.45 per 100,000 in 1990 to 0.1 per 100,000 in 1999. Although there is a nationwide shortage of rubella vaccine, women who are rubella susceptible during pregnancy should receive MMR (measles-mumps-rubella) vaccination postpartum. In October 2001, the federal Centers for Disease Control and Prevention changed the recommendations concerning the pregnancy interval after receiving rubella vaccine. This interval has been reduced from 3 months to 1 month.
D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011322:Primary Prevention / Q000379:methods; D012409:Rubella / Q000517:prevention & control*; D012410:Rubella Syndrome, Congenital / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D012680:Sensitivity and Specificity; D014611:Vaccination / Q000592:standards / Q000639:trends
D012411:Rubella Vaccine